Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine
Yangtao Wu, Shaojuan Wang, Yali Zhang, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 12, pp. 1732-1744.e7
Open Access | Times Cited: 21

Showing 21 citing articles:

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants
Lei Hong, Aqu Alu, H. J. Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
Congrui Zhu, Shengmei Pang, Jiaqi Liu, et al.
Drugs (2024) Vol. 84, Iss. 4, pp. 403-423
Closed Access | Times Cited: 9
Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants
Yali Zhang, Min Wei, Yangtao Wu, et al.
Cell Reports (2022) Vol. 38, Iss. 12, pp. 110558-110558
Open Access | Times Cited: 29
Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies
Shiqi Chen, Zehong Huang, Yue Guo, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies
Ohan Mazigi, David B. Langley, Jake Y. Henry, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 1
Open Access
A respiratory mucosal vaccine based on chitosan/aluminum adjuvant induces both mucosal and systemic immune responses
Ruitong Chen, Meifeng Nie, Yili Jiang, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125168-125168
Closed Access
Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites
Ciying Qian, Jie Chen, Yurou Yang, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
XA-Novo: an accurate and high-throughput mass spectrometry-based de novo sequencing technology for monoclonal antibodies and antibody mixtures
Yueting Xiong, Wenbin Jiang, Jin Xiao, et al.
Research Square (Research Square) (2025)
Closed Access
Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing
Puja Jaishwal, Kisalay Jha, Satarudra Prakash Singh
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134012-134012
Closed Access | Times Cited: 3
A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants
Jijing Chen, Zehong Huang, Jin Xiao, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 9, pp. 100856-100856
Open Access | Times Cited: 3
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
Jiansheng Jiang, Christopher T. Boughter, Javeed Ahmad, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
Brian G. Pierce, Nathaniel Felbinger, Matthew C. Metcalf, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 803-803
Open Access | Times Cited: 2
Hepatitis C Virus E1E2 Structure, Diversity, and Implications for Vaccine Development
Brian G. Pierce, Nathaniel Felbinger, Mathew Metcalf, et al.
(2024)
Open Access | Times Cited: 1
TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models
Yang Shi, Zihan Wang, Jingjing Xu, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Design of the conserved epitope peptide of SARS-CoV-2 spike protein as the broad-spectrum COVID-19 vaccine
Ting‐Yu Chang, Chia‐Jung Li, Tai‐Ling Chao, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 1
Broad-spectrum vaccine via combined immunization routes triggers potent immunity to SARS-CoV-2 and its variants
Man Xing, Yihan Wang, Xinyu Wang, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 4
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
Jiansheng Jiang, Christopher T. Boughter, Javeed Ahmad, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies
Yan‐Ning Wang, Tianyun Gao, W. Li, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Immunogenicity and protective effects of recombinant bivalent COVID-19 vaccine in mice and rhesus macaques
Yuying Liu, Aijing Zhang, Yan Wang, et al.
Vaccine (2023) Vol. 41, Iss. 36, pp. 5283-5295
Open Access | Times Cited: 1
Micronanoparticled risedronate exhibits potent vaccine adjuvant effects
Meifeng Nie, Shuyu Wu, Yiyi Chen, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 369-383
Closed Access | Times Cited: 1
Page 1

Scroll to top